[Pubmed] Outcomes after robotic thymectomy in nonthymomatous versus thymomatous patients with acetylcholine-receptor-ant

[RSS-Bot]

Neuromuscul Disord. 2023 Mar 16;33(5):417-424. doi: 10.1016/j.nmd.2023.03.005. Online ahead of print.

ABSTRACT

The aim of this study was to investigate the surgical and long-term neurological outcomes of patients with acetylcholine-receptor-antibody-associated myasthenia gravis (AChR-MG) who underwent robotic thymectomy (RATS). We retrospectively analyzed the clinical-pathological data of all patients with AChR-MG who underwent RATS using the DaVinci® Robotic System at the MUMC+ between April 2004 and December 2018. Follow-up data were collected from 60 referring Dutch hospitals. In total, 230 myasthenic patients including 76 patients with a thymoma (33.0%) were enrolled in this study. Mean follow-up time, procedure time and hospitalization were, respectively 65.7 ± 43.1 months, 111±52.5 min and 3.3 ± 2.2 days. Thymomatous patients had significantly more frequently and more severe complications than nonthymomatous patients (18.4% vs. 3.9%, p

Source: https://pubmed.ncbi.nlm.nih.gov/3703705 ... t6+86293ac